Phosphorylation of BLM, dissociation from topoisomerase IIIα, and colocalization with γ-H2AX after topoisomerase I-induced replication damage

Molecular and Cellular Biology

Volumn 25, Issue 20, 2005, Pages 8925-8937

  Rao, V Ashutosh ^a   Fan, Angela M ^a   Meng, LingHua ^a   Doe, Christopher F ^a   North, Phillip S ^b   Hickson, Ian D ^b   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BLOOM SYNDROME PROTEIN; CAMPTOTHECIN; DNA DEPENDENT PROTEIN KINASE; DNA TOPOISOMERASE; DNA TOPOISOMERASE IIIA; DOUBLE STRANDED DNA; H2 ANTIGEN; HYDROXYUREA; PROMYELOCYTIC LEUKEMIA PROTEIN; SINGLE STRANDED DNA; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOM SYNDROME; COMPLEX FORMATION; COVALENT BOND; DNA CLEAVAGE; DNA DAMAGE; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FIBROBLAST; GENETIC COMPLEMENTATION; HOLLIDAY JUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOSINE TRIPHOSPHATASES; BLOOM SYNDROME; CAMPTOTHECIN; CELL CYCLE PROTEINS; CELL LINE; DNA DAMAGE; DNA HELICASES; DNA REPAIR; DNA REPLICATION; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE I, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE; HISTONES; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 26444467122     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.20.8925-8937.2005     Document Type: Article

References (75)

1. Ababou, M., V. Dumaire, Y. Lecluse, and M. Amor-Gueret. 2002. Bloom's syndrome protein response to ultraviolet-C radiation and hydroxyurea-mediated DNA synthesis inhibition. Oncogene 21:2079-2088.
2. Ababou, M., S. Dutertre, Y. Lecluse, R. Onclercq, B. Chatton, and M. Amor-Gueret. 2000. ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation. Oncogene 19:5955-5963.
3. Aladjem, M. I., S. Pasa, S. Parodi, J. N. Weinstein, Y. Pommier, and K. W. Kohn. 2004. Molecular interaction maps - a diagrammatic graphical language for bioregulatory networks. Sci. STKE 2004:pe8.
4. Barnett, A. A. 1996. FDA approve bark-derived drug. Lancet 347:1613.
5. Bassing, C. H., and F. W. Alt. 2004. H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle 3:149-153.
6. Bastin-Shanower, S. A., W. M. Fricke, J. R. Mullen, and S. J. Brill. 2003. The mechanism of Mus81-Mms4 cleavage site selection distinguishes it from the homologous endonuclease Rad1-Rad10. Mol. Cell. Biol. 23:3487-3496.
7. Beamish, H., P. Kedar, H. Kaneko, P. Chen, T. Fukao, C. Peng, S. Beresten, N. Gueven, D. Purdie, S. Lees-Miller, N. Ellis, N. Kondo, and M. F. Lavin. 2002. Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM. J. Biol. Chem. 277:30515-30523.
8. Bernardi, R., and P. P. Pandolfi. 2003. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22:9048-9057.
9. Biamonti, G. 2004. Nuclear stress bodies: a heterochromatin affair? Nat. Rev. Mol. Cell. Biol. 5:493-498.
10. Bjergbaek, L., J. A. Cobb, M. Tsai-Pflugfelder, and S. M. Gasser. 2005. Mechanistically distinct roles for Sgs1p in checkpoint activation and replication fork maintenance. EMBO J. 24:405-417.
11. Champoux, J. J. 2001. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70:369-413.
12. Cliby, W. A., C. J. Roberts, K. A. Cimprich, C. M. Stringer, J. R. Lamb, S. L. Schreiber, and S. H. Friend. 1998. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17:159-169.
13. Davalos, A. R., and J. Campisi. 2003. Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks. J. Cell Biol. 162:1197-1209.
14. Davalos, A. R., P. Kaminker, R. K. Hansen, and J. Campisi. 2004. ATR and ATM-dependent movement of BLM helicase during replication stress ensures optimal ATM activation and 53BP1 focus formation. Cell Cycle 3:1579-1586.
15. Davies, S. L., P. S. North, A. Dart, N. D. Lakin, and I. D. Hickson. 2004. Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest. Mol. Cell. Biol. 24:1279-1291.
16. Dellaire, G., and D. P. Bazett-Jones. 2004. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963-977.
17. Doe, C. L., J. S. Ahn, J. Dixon, and M. C. Whitby. 2002. Mus81-Eme1 and Rqh1 involvement in processing stalled and collapsed replication forks. J. Biol. Chem. 277:32753-32759.
18. Eladad, S., T. Z. Ye, P. Hu, M. Leversha, S. Beresten, M. J. Matunis, and N. A. Ellis. 2005. Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification. Hum. Mol. Genet.
19. Eskiw, C. H., G. Dellaire, and D. P. Bazett-Jones. 2004. Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J. Biol. Chem. 279:9577-9585.
20. Fernandez-Capetillo, O., A. Lee, M. Nussenzweig, and A. Nussenzweig. 2004. H2AX: the histone guardian of the genome. DNA Repair 3:959-967.
21. Franchitto, A., and P. Pichierri. 2002. Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest. J. Cell Biol. 157:19-30.
22. Franchitto, A., and P. Pichierri. 2002. Protecting genomic integrity during DNA replication: correlation between Werner's and Bloom's syndrome gene products and the MRE11 complex. Hum. Mol. Genet. 11:2447-2453.
23. Furuta, T., H. Takemura, Z. Y. Liao, G. J. Aune, C. Redon, O. A. Sedelnikova, D. R. Pilch, E. P. Rogakou, A. Celeste, H. T. Chen, A. Nussenzweig, M. I. Aladjem, W. M. Bonner, and Y. Pommier. 2003. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 278:20303-20312.
24. Gangloff, S., B. de Massy, L. Arthur, R. Rothstein, and F. Fabre. 1999. The essential role of yeast topoisomerase III in meiosis depends on recombination. EMBO J. 18:1701-1711.
25. Gaymes, T. J., P. S. North, N. Brady, I. D. Hickson, G. J. Mufti, and F. V. Rassool. 2002. Increased error-prone non-homologous DNA end-joining - a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene 21:2525-2533.
26. Goodwin, A., S. W. Wang, T. Toda, C. Norbury, and I. D. Hickson. 1999. Topoisomerase III is essential for accurate nuclear division in Schizosaccharomyces pombe. Nucleic Acids Res. 27:4050-4058.
27. Heyer, W. D. 2004. Damage signaling: RecQ sends an SOS to you. Curr. Biol. 14:R895-R897.
28. Hickson, I. D. 2003. RecQ helicases: caretakers of the genome. Nat. Rev. Cancer 3:169-178.
29. Hodges, M., C. Tissot, K. Howe, D. Grimwade, and P. S. Freemont. 1998. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63:297-304.
30. Hofmann, T. G., and H. Will. 2003. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10:1290-1299.
31. Holm, C., J. M. Covey, D. Kerrigan, and Y. Pommier. 1989. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res. 49:6365-6368.
32. Hoppe, B. S., R. B. Jensen, and C. U. Kirchgessner. 2000. Complementation of the radiosensitive M059J cell line. Radiat. Res. 153:125-130.
33. Hsiang, Y. H., R. Hertzberg, S. Hecht, and L. F. Liu. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873-14878.
34. Hsiang, Y. H., M. G. Lihou, and L. F. Liu. 1989. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:5077-5082.
35. Hu, P., S. F. Beresten, A. J. van Brabant, T. Z. Ye, P. P. Pandolfi, F. B. Johnson, L. Guarente, and N. A. Ellis. 2001. Evidence for BLM and topoisomerase IIIα interaction in genomic stability. Hum. Mol. Genet. 10:1287-1298.
36. Huber, M. D., D. C. Lee, and N. Maizels. 2002. G4 DNA unwinding by BLM and Sgs1p: substrate specificity and substrate-specific inhibition. Nucleic Acids Res. 30:3954-3961.
37. Johnson, F. B., D. B. Lombard, N. F. Neff, M. A. Mastrangelo, W. Dewolf, N. A. Ellis, R. A. Marciniak, Y. Yin, R. Jaenisch, and L. Guarente. 2000. Association of the Bloom syndrome protein with topoisomerase IIIα in somatic and meiotic cells. Cancer Res. 60:1162-1167.
38. Karow, J. K., A. Constantinou, J. L. Li, S. C. West, and I. D. Hickson. 2000. The Bloom's syndrome gene product promotes branch migration of holliday junctions. Proc. Natl. Acad. Sci. USA 97:6504-6508.
39. Khakhar, R. R., J. A. Cobb, L. Bjergbaek, I. D. Hickson, and S. M. Gasser. 2003. RecQ helicases: multiple roles in genome maintenance. Trends Cell Biol. 13:493-501.
40. Li, W., S. M. Kim, J. Lee, and W. G. Dunphy. 2004. Absence of BLM leads to accumulation of chromosomal DNA breaks during both unperturbed and disrupted S phases. J. Cell Biol. 165:801-812.
41. Liao, S., J. Graham, and H. Yan. 2000. The function of Xenopus Bloom's syndrome protein homolog (xBLM) in DNA replication. Genes Dev. 14:2570-2575.
42. Lou, Z., B. P. Chen, A. Asaithamby, K. Minter-Dykhouse, D. J. Chen, and J. Chen. 2004. MDC1 regulates DNA-PK autophosphorylation in response to DNA damage. J. Biol. Chem. 279:46359-46362.
43. Lou, Z., C. C. Chini, K. Minter-Dykhouse, and J. Chen. 2003. Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control. J. Biol. Chem. 278:13599-13602.
44. Onclercq-Delic, R., P. Calsou, C. Delteil, B. Salles, D. Papadopoulo, and M. Amor-Gueret. 2003. Possible anti-recombinogenic role of Bloom's syndrome helicase in double-strand break processing. Nucleic Acids Res. 31:6272-6282.
45. Paull, T. T., E. P. Rogakou, V. Yamazaki, C. U. Kirchgessner, M. Gellert, and W. M. Bonner. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:886-895.
46. Pizzolato, J. F., and L. B. Saltz. 2003. The camptothecins. Lancet 361:2235-2242.
47. Pommier, Y., and J. Cherfils. 2005. Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. Trends Pharmacol. Sci. 26:138-145.
48. Pommier, Y., C. Redon, V. A. Rao, J. A. Seiler, O. Sordet, H. Takemura, S. Antony, L. Meng, Z. Liao, G. Kohlhagen, H. Zhang, and K. W. Kohn. 2003. Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat. Res. 532:173-203.
49. Pourquier, P., and Y. Pommier. 2001. Topoisomerase I-mediated DNA damage. Adv. Cancer Res. 80:189-216.
50. Pourquier, P., Y. Takebayashi, Y. Urasaki, C. Gioffre, G. Kohlhagen, and Y. Pommier. 2000. Induction of topoisomerase I cleavage complexes by 1-beta-D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells. Proc. Natl. Acad. Sci. USA 97:1885-1890.
51. Pourquier, P., L. M. Ueng, G. Kohlhagen, A. Mazumder, M. Gupta, K. W. Kohn, and Y. Pommier. 1997. Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J. Biol. Chem. 272:7792-7796.
52. Rassool, F. V., P. S. North, G. J. Mufti, and I. D. Hickson. 2003. Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cells. Oncogene 22:8749-8757.
53. Redon, C., D. R. Pilch, E. P. Rogakou, A. H. Orr, N. F. Lowndes, and W. M. Bonner. 2003. Yeast histone 2A serine 129 is essential for the efficient repair of checkpoint-blind DNA damage. EMBO Rep. 4:678-684.
54. Rogakou, E. P., D. R. Pilch, A. H. Orr, V. S. Ivanova, and W. M. Bonner. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858-5868.
55. Rothstein, R., B. Michel, and S. Gangloff. 2000. Replication fork pausing and recombination or "gimme a break." Genes Dev. 14:1-10.
56. Ruggero, D., Z. G. Wang, and P. P. Pandolfi. 2000. The puzzling multiple lives of PML and its role in the genesis of cancer. Bioessays 22:827-835.
57. Salomoni, P., and P. P. Pandolfi. 2002. The role of PML in tumor suppression. Cell 108:165-170.
58. Sengupta, S., A. I. Robles, S. P. Linke, N. I. Sinogeeva, R. Zhang, R. Pedeux, I. M. Ward, A. Celeste, A. Nussenzweig, J. Chen, T. D. Halazonetis, and C. C. Harris. 2004. Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J. Cell Biol. 166:801-813.
59. Shao, R. G., C. X. Cao, H. Zhang, K. W. Kohn, M. S. Wold, and Y. Pommier. 1999. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA: DNA-PK complexes. EMBO J. 18:1397-1406.
60. +, a fission yeast gene related to the Bloom's and Werner's syndrome genes, is required for reversible S phase arrest. EMBO J. 16:2682-2692.
61. Stewart, G. S., B. Wang, C. R. Bignell, A. M. Taylor, and S. J. Elledge. 2003. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421:961-966.
62. Strumberg, D., A. A. Pilon, M. Smith, R. Hickey, L. Malkas, and Y. Pommier. 2000. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′ phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell. Biol. 20:3977-3987.
63. Subramanian, D., C. S. Furbee, and M. T. Muller. 2001. ICE bioassay. Isolating in vivo complexes of enzyme to DNA. Methods Mol. Biol. 95:137-147.
64. Takimoto, C. H., and S. G. Arbuck. 1997. Clinical status and optimal use of topotecan. Oncology 11:1635-1646.
65. Tanizawa, A., K. W. Kohn, G. Kohlhagen, F. Leteurtre, and Y. Pommier. 1995. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry 34:7200-7206.
66. van Brabant, A. J., R. Stan, and N. A. Ellis. 2000. DNA helicases, genomic instability, and human genetic disease. Annu. Rev. Genomics Hum. Genet. 1:409-459.
67. Wang, J. C. 2002. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell. Biol. 3:430-440.
68. Wu, L., S. L. Davies, P. S. North, H. Goulaouic, J. F. Riou, H. Turley, K. C. Gatter, and I. D. Hickson. 2000. The Bloom's syndrome gene product interacts with topoisomerase III. J. Biol. Chem. 275:9636-9644.
69. Wu, L., and I. D. Hickson. 2002. The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIα. Nucleic Acids Res. 30:4823-4829.
70. Wu, L., and I. D. Hickson. 2003. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426:870-874.
71. Xu, Z. X., A. Timanova-Atanasova, R. X. Zhao, and K. S. Chang. 2003. PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol. Cell. Biol. 23:4247-4256.
72. Yankiwski, V., R. A. Marciniak, L. Guarente, and N. F. Neff. 2000. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA 97:5214-5219.
73. Yankiwski, V., J. P. Noonan, and N. F. Neff. 2001. The C-terminal domain of the Bloom syndrome DNA helicase is essential for genomic stability. BMC Cell Biol. 2:11.
74. Yin, J., A. Sobeck, C. Xu, A. R. Meetei, M. Hoatlin, L. Li, and W. Wang. 2005. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J.
75. Zhong, S., P. Hu, T. Z. Ye, R. Stan, N. A. Ellis, and P. P. Pandolfi. 1999. A role for PML and the nuclear body in genomic stability. Oncogene 18:7941-7947.